Navigation Links
Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
Date:10/29/2009

safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

    Table 1
                              Amicus Therapeutics, Inc.
                            (a development stage company)
                        Consolidated Statements of Operations
                                    (Unaudited)
                 (In thousands, except share and per share amounts)

                                                                 Period from
                                                                  February
                            Three Months         Nine Months       4, 2002
                               Ended                Ended      (inception) to
                            September 30,        September 30,   September 30,
                            -------------        ------------   -------------
                           2008       2009       2008      2009       2009
                           ----       ----       ----      ----       ----
    Revenue:
      Research revenue   $2,959     $4,219     $8,539    $12,799     $26,362
      Collaboration
       revenue              694        694      2,083      2,083       5,270
                            ---        ---      -----      -----       -----
    Total revenue         3,653      4,913     10,622     14,882      31,632
                          -----      -----     ------     ------      ------

    Operating Expenses:
      Research and
       development        8,200     12,609     23,989     37,954     165,596
      General and
       administrative     4,371      5,217     14,676     15,635      73,371
      Impairment of
       leasehold
       improvements           -          -          -          -       1,030
      Depreciation and
       amortization         382        561      1,036      1,585       5,872
      In-process research
       and development        -          -          -          -         418
                           
'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... RURO, Inc., Laboratory Information Management System ... the opening of its first international office. Located ... in Shanghai, PRC, RURO Shanghai’s doors are open. ... Mr. Shen Gang, the former Technical Director of ... RURO’s has installed FreezerPro-based solutions in more than ...
(Date:8/1/2014)... 2014 The  PROPEL Center  of the  iBIO ... rate of early-stage life sciences companies in ... 15 grants to help Illinois ...   in Chicago .   AdvaMed ... North America , bringing more than 1,000 ...
(Date:8/1/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... MARKETS , that the global market RNA interference (RNAi) ... $38.8 billion by 2018, with a five-year compound annual ... the fastest moving segment of the market, is moving ... RNAi therapeutics has shown tremendous growth and has moved ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... consumers, are increasingly searching for food alternatives that ... nutritional benefits. The food ingredient market has numerous ... players such as Vital Force Technology (VFT). ... more than 4,000 energetic patterns, all tested to ...
Breaking Biology Technology:RURO Opens Office in Shanghai, China 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 3iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 4Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR 2Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR 3Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2
... probably know who signs the paychecks in your organization. Most ... who reports to whom. We might even know one or ... not tell you much about who your IT staff is ... IT staff members become moles in your organization as they ...
... RmSys, Inc. has announced its formation based on ... and Innovation, Inc. RmSys will be using the ... Ram Bhatia, chief operating officer of RmSys indicated the ... its agricultural chemical leaching inhibition technology. , ,CATI ...
... engine of future economic growth, Wisconsin is running low on ... Institute ranks our state 32nd out of 50 in availability ... innovative ideas into marketplace successes. That may soon change ... by Governor Doyle. , ,Act 255 encourages angel investors and ...
Cached Biology Technology:Who does your IT staff work for? 2Who does your IT staff work for? 3An analysis of Wisconsins new venture capital and early stage finance programs 2An analysis of Wisconsins new venture capital and early stage finance programs 3
(Date:7/31/2014)... news release is available in German . ... can take up gases similar to a sponge that ... suited for storing hydrogen or greenhouse gases. However, loading ... Karlsruhe Institute of Technology (KIT) now report in ... cor-rosion of the MOF surface. This can be prevented ...
(Date:7/31/2014)... Prolonged exposure to loud noise alters how the ... distinguishing speech sounds, according to neuroscientists at The ... paper published this week in Ear and ... how noise-induced hearing loss affects the brain,s recognition ... reaches all corners of the population, affecting an ...
(Date:7/31/2014)... week that the U.S. surgeon general issued a 101-page ... Montana State University published a paper breaking new ground ... cell responds when exposed to ultraviolet (UV) light. ... by the UV rays found in sunlight. This damage ... eye diseases. , "Our paper advances foundational knowledge ...
Breaking Biology News(10 mins):Free pores for molecule transport 2UT Dallas study reveals effect of loud noises on brain 2New paper describes how DNA avoids damage from UV light 2New paper describes how DNA avoids damage from UV light 3
... Bacteria can directly cause human blood and plasma to ... lost during the course of vertebrate evolution, according to ... of Allergy and Infectious Diseases, and Institut Pasteur in ... in Nature Chemical Biology . , The discovery ...
... designing and manufacturing biomedical sensors, healthcare and its related ... learn what to expect from this new and growing ... seminar set for Nov. 6, 2008, from 4:45-6 p.m., ... (ECE) Building, 141 Warren St, at the northwest corner ...
... in Italy have found bacteria in the root of ... the cosmetic and perfumery industries. These bacteria seem to ... change the molecular structure of the oil, giving it ... Studying the root of the tropical Vetiver grass ...
Cached Biology News:Nature study demonstrates that bacterial clotting depends on clustering 2NJIT seminar set for Nov. 6 to focus on bioelectronics -- emerging research area 2Bacteria manage perfume oil production from grass 2
AedestaTM Animal Organ/Tissue Perfusion Soln....
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
... Spots, Oligo Spots and complementary RNA Spikes ... experiments. Use for glass array printing and ... reverse transcription, cDNA labeling, hybridization stringency and ... Control PCR Spots and Oligo Spots, and ...
Biology Products: